Emerging Therapies in IgA Nephropathy: The Rationale for Targeting APRIL

1 Apr 2023 13:00 14:00

MR 111

Organized by Otsuka Visterra

Organized by

Time	Session

13:00 13:20	Review background on IgAN and the multi-hit IgAN pathogenesis
13:20 13:40	Discuss B-cell biology and rationale for targeting APRIL
13:40 14:00	Present overview of existing clinical evidence supporting targeting APRIL in IgAN